Neurosciences -> Neurology and Psychiatry 1469

1469 - Disrupted metabolic network in the cholinergic projection region in cognitive decline (ID 1159)

Session Name
Neurology & Psychiatry Imaging Posters
Speakers
Authors
Presentation Topic
Neurosciences -> Neurology and Psychiatry
Presentation Number
1469

Previous Eposter
1463 - Imaging of neurodegenerative diseases using Tau PET/CT with [11C]PBB3 in a clinical setting (ID 1153)

Next Eposters
1470 - In vivo imaging of brain muscarinic receptors with 18F-Flurobenzyl Dexetimide: First in human studies (ID 1160)
1472 - Dual-model Radiomic biomarkers predict development of Mild Cognitive Impairment progression to Alzheimer’s disease (ID 1162)
1476 - Change of cerebral blood flow and glucose metabolism in patients with ischemic cerebrovascular disease (ID 1166)
1477 - Early 18F-Florapronol brain PET images may be used as additional biomarker such as 18F-FDG brain PET. (ID 1167)
1479 - Role of FDG PET scan in seizure focus localization in patients with unremarkable brain MRI (ID 1169)
1481 - Predicting surgical outcomes for patients with complicated refractory seizures. (ID 1171)
1484 - The correlation of in vivo tau with amyloid beta, hypometabolism, and cortical atrophy in chronic TBI subjects. (ID 1174)
1487 - Relevance of spinal neuroinflammation to neuropathic pain: an exploratory clinical study evaluated by 11C-DPA-713 PET and TSPO-related biomarkers. (ID 1177)
1496 - Regional brain cholinergic system changes in Parkinson disease with RBD: an 18F-FEOBV PET study (ID 1186)
1502 - PET-CT tumor imaging with 64CuCl2: Early experience with brain tumor imaging (ID 1192)